Amin Ramezani

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

Iranian journal of immunology : IJI

BMC urology

PloS one

Molecular biology reports

Shiraz University of Medical Sciences

Shiraz University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shiraz University of Medical Sciences Jun 14 2017

Iran

Assistant Professor of Medical Biotechnology :: Shiraz Institute for Cancer Research

Education History

Shiraz University of Medical Sciences Jan 20 2012 - Feb 18 2017

Iran

PHD :: Medical Biotechnology

Publications

Mohammadrasul Zareinejad, Zahra Faghih, Amin Ramezani, Akbar Safaei, Abbas Ghaderi
Exploring heterogeneous expression of beta-actin (ACTB) in bladder cancer by producing a monoclonal antibody 6D6. BMC urology 24 (1) (2024)
Mohammadrasul Zareinejad, Zahra Faghih, Amin Ramezani, Akbar Safaei, Abbas Ghaderi
Exploring heterogeneous expression of beta-actin (ACTB) in bladder cancer by producing a monoclonal antibody 6D6. BMC urology 24 (1) (2024)
Mohammadrasul Zareinejad, Zahra Faghih, Amin Ramezani, Akbar Safaei, Abbas Ghaderi
Exploring heterogeneous expression of beta-actin (ACTB) in bladder cancer by producing a monoclonal antibody 6D6. BMC urology 24 (1) (2024)
Maryam Asadi, Razie Kiani, Vahid Razban, Seyed Nooreddin Faraji, Amirhossein Ahmadi, Jafar Fallahi, Amin Ramezani, Nasrollah Erfani
Harnessing the Power of CAR-NK Cells: A Promising Off-the-Shelf Therapeutic Strategy for CD38-Positive Malignancies. Iranian journal of immunology : IJI 20 (4) (2023)
Leila Moeinzadeh, Amin Ramezani, Fereshteh Mehdipour, Mahsa Yazdanpanah-Samani, Mahboobeh Razmkhah
Activation of T Lymphocytes with Anti-PDL1-BiTE in the Presence of Adipose-Derived Mesenchymal Stem Cells (ASCs). BioMed research international 2023 (2023)
Amin Ramezani, Mohammadrasul Zareinejad, Elham Mahmoudi Maymand, Elina Kaviani, Abbas Ghaderi
Production of a biosimilar version of aflibercept to improve VEGF blocker cytotoxicity on endothelial cells. Growth factors (Chur, Switzerland) (2023)
Mohsen Mazloomrezaei, Mahsa Sadat Hosseini, Nahid Ahmadi, Elham Mahmoudi Maymand, Ebrahim Eftekhar, Amir Asgari, Amin Ramezani
Introducing a New Method for Purification of Human IL-4 by Substitution of a Single Amino Acid in IL-4 Protein Sequence. Iranian journal of immunology : IJI 19 (4) (2023)
Maryam Asadi, Razie Kiani, Vahid Razban, Seyed Nooreddin Faraji, Amirhossein Ahmadi, Jafar Fallahi, Amin Ramezani, Nasrollah Erfani
Harnessing the Power of CAR-NK Cells: A Promising Off-the-Shelf Therapeutic Strategy for CD38-Positive Malignancies. Iranian journal of immunology : IJI 20 (4) (2023)
Maryam Asadi, Razie Kiani, Vahid Razban, Seyed Nooreddin Faraji, Amirhossein Ahmadi, Jafar Fallahi, Amin Ramezani, Nasrollah Erfani
Harnessing the Power of CAR-NK Cells: A Promising Off-the-Shelf Therapeutic Strategy for CD38-Positive Malignancies. Iranian journal of immunology : IJI 20 (4) (2023)
Maryam Asadi, Razie Kiani, Vahid Razban, Seyed Nooreddin Faraji, Amirhossein Ahmadi, Jafar Fallahi, Amin Ramezani, Nasrollah Erfani
Harnessing the Power of CAR-NK Cells: A Promising Off-the-Shelf Therapeutic Strategy for CD38-Positive Malignancies. Iranian journal of immunology : IJI 20 (4) (2023)
Parisa Soltan-Alinejad, Hamzeh Alipour, Aboozar Soltani, Qasem Asgari, Amin Ramezani, Davood Mehrabani, Kourosh Azizi
Molecular Characterization and In Silico Analyses of Maurolipin Structure as a Secretory Phospholipase A 2 (sPLA 2 ) from Venom Glands of Iranian Scorpio maurus (Arachnida: Scorpionida). Journal of tropical medicine 2022 (2022)
Elina Kaviani, Ahmad Hosseini, Elham Mahmoudi Maymand, Mani Ramzi, Abbas Ghaderi, Amin Ramezani
Triggering of lymphocytes by CD28, 4-1BB, and PD-1 checkpoints to enhance the immune response capacities. PloS one 17 (12) (2022)
Maryam Asadi, Nahid Ahmadi, Simin Ahmadvand, Ali Akbar Jafari, Akbar Safaei, Nasrollah Erfani, Amin Ramezani
Investigation of olfactory receptor family 51 subfamily j member 1 (OR51J1) gene susceptibility as a potential breast cancer-associated biomarker. PloS one 16 (2) (2021)
Amir Asgari, Sedigheh Sharifzadeh, Abbas Ghaderi, Ahmad Hosseini, Amin Ramezani
In vitro cytotoxic effect of Trastuzumab in combination with Pertuzumab in breast cancer cells is improved by interleukin-2 activated NK cells. Molecular biology reports 46 (6) (2019)

Amin Ramezani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amin Ramezani